EI
BDTX icon

Ethic Inc’s Black Diamond Therapeutics BDTX Stock Holding History

Ethic Inc’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,695
Closed -$22.8K – 1367
2026
Q1 		$22.8K Sell
10,695
-4,753
-31% -$11.3K ﹤0.01% 1229
2025
Q4 		$37.5K Sell
15,448
-144
-0.9% -$510 ﹤0.01% 1196
2025
Q3 		$59.1K Buy
+15,592
New +$45.6K ﹤0.01% 1173

Other funds holding BDTX

DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
KCM
Kathmere Capital Management Wayne, Pennsylvania $1.89B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return

Ethic Inc's BDTX Position: Q2 2026 in Review

Ethic Inc sold out of Black Diamond Therapeutics (BDTX) in Q2 2026, closing a stake of 10,695 shares — an estimated $22.8K sold.

Ethic Inc first reported a position in BDTX in Q3 2025 and held it in 3 quarters. The position peaked at $59.1K in Q3 2025. 12 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Ethic Inc reported no remaining Black Diamond Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Ethic Inc sold 10,695 Black Diamond Therapeutics shares in Q2 2026, an estimated $22.8K.
  • Ethic Inc first reported a position in Black Diamond Therapeutics in Q3 2025 and held it in 3 quarters.
  • Ethic Inc's Black Diamond Therapeutics position peaked at $59.1K in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Ethic Inc's 13F filing for Q2 2026, filed 29 Jul 2026.